Skip to main content
Top
Published in: The Journal of Headache and Pain 1/2011

Open Access 01-02-2011 | Original

Risk factors of migraine-related brain white matter hyperintensities: an investigation of 186 patients

Authors: Anita Trauninger, Eszter Leél-Őssy, David Olayinka Kamson, László Pótó, Mihály Aradi, Ferenc Kövér, Marianna Imre, Hedvig Komáromy, Szilvia Erdélyi-Botor, Ágnes Patzkó, Zoltán Pfund

Published in: The Journal of Headache and Pain | Issue 1/2011

Login to get access

Abstract

Brain white matter hyperintensities are more prevalent in migraine patients than in the general population, but the pathogenesis and the risk factors of these hyperintensities are not fully elucidated. The authors analyzed the routine clinical data of 186 migraine patients who were referred to the Outpatient Headache Department of the Department of Neurology, Medical School, University of Pécs, Hungary between 2007 and 2009: 58 patients with white matter hyperintensities and 128 patients without white matter hyperintensities on 3 T MRI. Significant associations between the presence of white matter hyperintensities and longer disease duration (14.4 vs. 19.9 years, p = 0.004), higher headache frequency (4.1 vs. 5.5 attacks/month, p = 0.017), hyperhomocysteinemia (incidence of hyperintensity is 9/9 = 100%, p = 0.009) and thyroid gland dysfunction (incidence of hyperintensity is 8/14 = 57.1%, p = 0.038) were found. These data support the theory that both the disease duration and the attack frequency have a key role in the formation of migraine-related brain white matter hyperintensities, but the effects of comorbid diseases may also contribute to the development of the hyperintensities.
Literature
1.
go back to reference Kruit MC, van Buchem MA, Hofman PA, Bakkers JT, Terwindt GM, Ferrari MD, Launer LJ (2004) Migraine is a risk factor for subclinical brain lesions. JAMA 291:427–434, 14747499, 10.1001/jama.291.4.427, 1:CAS:528:DC%2BD2cXos1Smsg%3D%3DCrossRefPubMed Kruit MC, van Buchem MA, Hofman PA, Bakkers JT, Terwindt GM, Ferrari MD, Launer LJ (2004) Migraine is a risk factor for subclinical brain lesions. JAMA 291:427–434, 14747499, 10.1001/jama.291.4.427, 1:CAS:528:DC%2BD2cXos1Smsg%3D%3DCrossRefPubMed
2.
go back to reference Kruit MC, Launer LJ, Ferrari MD, van Buchem MA (2005) Infarcts in the posterior circulation territory in migraine. The population-based MRI CAMERA study. Brain 128:2068–2077, 16006538, 10.1093/brain/awh542CrossRefPubMed Kruit MC, Launer LJ, Ferrari MD, van Buchem MA (2005) Infarcts in the posterior circulation territory in migraine. The population-based MRI CAMERA study. Brain 128:2068–2077, 16006538, 10.1093/brain/awh542CrossRefPubMed
3.
go back to reference Kruit MC, Launer LJ, Ferrari MD, van Buchem MA (2006) Brain stem and cerebellar hyperintense lesions in migraine. Stroke 37:1109–1112, 16497982, 10.1161/01.STR.0000206446.26702.e9CrossRefPubMed Kruit MC, Launer LJ, Ferrari MD, van Buchem MA (2006) Brain stem and cerebellar hyperintense lesions in migraine. Stroke 37:1109–1112, 16497982, 10.1161/01.STR.0000206446.26702.e9CrossRefPubMed
4.
go back to reference Kruit MC, van Buchem MA, Launer LJ, Terwindt GM, Ferrari MD (2010) Migraine is associated with an increased risk of deep white matter lesions, subclinical posterior circulation infarcts and brain iron accumulations: the population-based MRI CAMERA study. Cephalalgia 30:129–136, 19515125, 1:STN:280:DC%2BC3cfntVSrtQ%3D%3DPubMedCentralPubMed Kruit MC, van Buchem MA, Launer LJ, Terwindt GM, Ferrari MD (2010) Migraine is associated with an increased risk of deep white matter lesions, subclinical posterior circulation infarcts and brain iron accumulations: the population-based MRI CAMERA study. Cephalalgia 30:129–136, 19515125, 1:STN:280:DC%2BC3cfntVSrtQ%3D%3DPubMedCentralPubMed
5.
go back to reference Swartz RH, Kern RZ (2004) Migraine is associated with magnetic resonance imaging white matter abnormalities: a meta-analysis. Arch Neurol 61:1366–1368, 15364681, 10.1001/archneur.61.9.1366CrossRefPubMed Swartz RH, Kern RZ (2004) Migraine is associated with magnetic resonance imaging white matter abnormalities: a meta-analysis. Arch Neurol 61:1366–1368, 15364681, 10.1001/archneur.61.9.1366CrossRefPubMed
6.
go back to reference Schmitz N, Admiraal-Behloul F, Arkink EB, Kruit MC, Schoonman GG, Ferrari MD, van Buchem MA (2008) Attack frequency and disease duration as indicators for brain damage in migraine. Headache 48:1044–1055, 18479421, 10.1111/j.1526-4610.2008.01133.xCrossRefPubMed Schmitz N, Admiraal-Behloul F, Arkink EB, Kruit MC, Schoonman GG, Ferrari MD, van Buchem MA (2008) Attack frequency and disease duration as indicators for brain damage in migraine. Headache 48:1044–1055, 18479421, 10.1111/j.1526-4610.2008.01133.xCrossRefPubMed
7.
go back to reference Fazekas F, Koch M, Schmidt R, Offenbacher H, Payer F, Freidl W, Lechner H (1992) The prevalence of cerebral damage varies with migraine type: a MRI study. Headache 32:287–291, 1399549, 10.1111/j.1526-4610.1992.hed3206287.x, 1:STN:280:DyaK3s%2FhsVykuw%3D%3DCrossRefPubMed Fazekas F, Koch M, Schmidt R, Offenbacher H, Payer F, Freidl W, Lechner H (1992) The prevalence of cerebral damage varies with migraine type: a MRI study. Headache 32:287–291, 1399549, 10.1111/j.1526-4610.1992.hed3206287.x, 1:STN:280:DyaK3s%2FhsVykuw%3D%3DCrossRefPubMed
8.
go back to reference Benedittis GD, Lorenzetti A, Sina C, Bernasconi V (1995) Magnetic resonance imaging in migraine and tension-type headache. Headache 35:264–268, 7775189, 10.1111/j.1526-4610.1995.hed3505264.xCrossRefPubMed Benedittis GD, Lorenzetti A, Sina C, Bernasconi V (1995) Magnetic resonance imaging in migraine and tension-type headache. Headache 35:264–268, 7775189, 10.1111/j.1526-4610.1995.hed3505264.xCrossRefPubMed
9.
go back to reference Sacco S, Olivieri L, Bastianello S, Carolei A (2006) Comorbid neuropathologies in migraine. J Headache Pain 7:222–230, 16767530, 10.1007/s10194-006-0300-8PubMedCentralCrossRefPubMed Sacco S, Olivieri L, Bastianello S, Carolei A (2006) Comorbid neuropathologies in migraine. J Headache Pain 7:222–230, 16767530, 10.1007/s10194-006-0300-8PubMedCentralCrossRefPubMed
10.
go back to reference Sacco S, Cerone D, Carolei A (2008) Comorbid neuropathologies in migraine: an update on cerebrovascular and cardiovascular aspects. J Headache Pain 9:237–248, 18600300, 10.1007/s10194-008-0048-4PubMedCentralCrossRefPubMed Sacco S, Cerone D, Carolei A (2008) Comorbid neuropathologies in migraine: an update on cerebrovascular and cardiovascular aspects. J Headache Pain 9:237–248, 18600300, 10.1007/s10194-008-0048-4PubMedCentralCrossRefPubMed
11.
go back to reference Dodick DW, Roarke MC (2007) Crossed cerebellar diaschisis during migraine with prolonged aura: a possible mechanism for cerebellar infarction. Cephalalgia 28:83–86, 17970765PubMed Dodick DW, Roarke MC (2007) Crossed cerebellar diaschisis during migraine with prolonged aura: a possible mechanism for cerebellar infarction. Cephalalgia 28:83–86, 17970765PubMed
12.
go back to reference Longoni M, Ferrarese C (2006) Inflammation and excitotoxicity: role in migraine pathogenesis. Neurol Sci Suppl 2:S107–S110, 10.1007/s10072-006-0582-2CrossRef Longoni M, Ferrarese C (2006) Inflammation and excitotoxicity: role in migraine pathogenesis. Neurol Sci Suppl 2:S107–S110, 10.1007/s10072-006-0582-2CrossRef
13.
go back to reference Robbins L, Friedman H (1992) MRI in migraineurs. Headache 32:507–508, 1468910, 10.1111/j.1526-4610.1992.hed3210507.x, 1:STN:280:DyaK3s7gs1Olsg%3D%3DCrossRefPubMed Robbins L, Friedman H (1992) MRI in migraineurs. Headache 32:507–508, 1468910, 10.1111/j.1526-4610.1992.hed3210507.x, 1:STN:280:DyaK3s7gs1Olsg%3D%3DCrossRefPubMed
14.
go back to reference Sparaco M, Feleppa M, Lipton RB, Rapoport AM, Bigal ME (2006) Mitochondrial dysfunction in migraine: evidence and hypotheses. Cephalalgia 26:361–372, 16556237, 10.1111/j.1468-2982.2005.01059.x, 1:STN:280:DC%2BD283gs1ersw%3D%3DCrossRefPubMed Sparaco M, Feleppa M, Lipton RB, Rapoport AM, Bigal ME (2006) Mitochondrial dysfunction in migraine: evidence and hypotheses. Cephalalgia 26:361–372, 16556237, 10.1111/j.1468-2982.2005.01059.x, 1:STN:280:DC%2BD283gs1ersw%3D%3DCrossRefPubMed
15.
go back to reference Blake GJ, Ridker PM (2001) Novel clinical markers of vascular wall inflammation. Circ Res 89:763–771, 11679405, 10.1161/hh2101.099270, 1:CAS:528:DC%2BD3MXot1ynu70%3DCrossRefPubMed Blake GJ, Ridker PM (2001) Novel clinical markers of vascular wall inflammation. Circ Res 89:763–771, 11679405, 10.1161/hh2101.099270, 1:CAS:528:DC%2BD3MXot1ynu70%3DCrossRefPubMed
16.
go back to reference Munno I, Centozone V, Marinaro M, Bassi A, Lacedra G, Causarano V, Nardelli P, Cassiano MA, Albano O (1998) Cytokines and migraine: increase of IK-5 an IL-4 plasma levels. Headache 38:465–467, 9664752, 10.1046/j.1526-4610.1998.3806465.x, 1:STN:280:DyaK1czivFCmtg%3D%3DCrossRefPubMed Munno I, Centozone V, Marinaro M, Bassi A, Lacedra G, Causarano V, Nardelli P, Cassiano MA, Albano O (1998) Cytokines and migraine: increase of IK-5 an IL-4 plasma levels. Headache 38:465–467, 9664752, 10.1046/j.1526-4610.1998.3806465.x, 1:STN:280:DyaK1czivFCmtg%3D%3DCrossRefPubMed
17.
go back to reference Sarchielli P, Alberti A, Baldi A, Coppola F, Rossi C, Pierguidi L, Floridi A, Calabresi P (2006) Proinflammatory cytokines, adhesion molecules and lymphocyte integrin expression in the internal jugular blood of migraine patients without aura assessed ictally. Headache 46:200–207, 16492228, 10.1111/j.1526-4610.2006.00337.xCrossRefPubMed Sarchielli P, Alberti A, Baldi A, Coppola F, Rossi C, Pierguidi L, Floridi A, Calabresi P (2006) Proinflammatory cytokines, adhesion molecules and lymphocyte integrin expression in the internal jugular blood of migraine patients without aura assessed ictally. Headache 46:200–207, 16492228, 10.1111/j.1526-4610.2006.00337.xCrossRefPubMed
18.
go back to reference Moskowitz MA, Macfarlane R (1993) Neurovascular and molecular mechanisms in migraine headaches. Cerebrovasc Brain Metab Rev 5:159–177, 8217498, 1:STN:280:DyaK2c%2FjtFCnuw%3D%3DPubMed Moskowitz MA, Macfarlane R (1993) Neurovascular and molecular mechanisms in migraine headaches. Cerebrovasc Brain Metab Rev 5:159–177, 8217498, 1:STN:280:DyaK2c%2FjtFCnuw%3D%3DPubMed
19.
go back to reference Welch KM (2003) Stroke and migraine—the spectrum of cause and effect. Funct Neurol 18:121–126, 14703893PubMed Welch KM (2003) Stroke and migraine—the spectrum of cause and effect. Funct Neurol 18:121–126, 14703893PubMed
20.
go back to reference Gursoy-Ozdemir Y, Qiu J, Matsuoka N, Bolay H, Bermpohl D, Jin H, Wang X, Rosenberg GA, Lo EH, Moskowitz MA (2004) Cortical spreading depression activates and upregulates MMP-9. J Clin Invest 113:1447–1455, 15146242, 1:CAS:528:DC%2BD2cXktlCltrY%3DPubMedCentralCrossRefPubMed Gursoy-Ozdemir Y, Qiu J, Matsuoka N, Bolay H, Bermpohl D, Jin H, Wang X, Rosenberg GA, Lo EH, Moskowitz MA (2004) Cortical spreading depression activates and upregulates MMP-9. J Clin Invest 113:1447–1455, 15146242, 1:CAS:528:DC%2BD2cXktlCltrY%3DPubMedCentralCrossRefPubMed
21.
go back to reference Lea RA, Ovcaric M, Sundholm J, MacMillan J, Griffiths LR (2004) The methylenetetrahydrofolate reductase gene variant C677T influences susceptibility to migraine with aura. BMC Med 2:3, 15053827, 10.1186/1741-7015-2-3PubMedCentralCrossRefPubMed Lea RA, Ovcaric M, Sundholm J, MacMillan J, Griffiths LR (2004) The methylenetetrahydrofolate reductase gene variant C677T influences susceptibility to migraine with aura. BMC Med 2:3, 15053827, 10.1186/1741-7015-2-3PubMedCentralCrossRefPubMed
22.
go back to reference Tietjen GE, Herial NA, Utley C, White L, Yerga-Woolwine S, Joe B (2009) Association of von Willebrand factor activity with ACE I/D and MTHFR C677T polymorphisms in migraine. Cephalalgia 29:960–968, 19298544, 10.1111/j.1468-2982.2008.01824.x, 1:STN:280:DC%2BD1Mrmt1aktA%3D%3DCrossRefPubMed Tietjen GE, Herial NA, Utley C, White L, Yerga-Woolwine S, Joe B (2009) Association of von Willebrand factor activity with ACE I/D and MTHFR C677T polymorphisms in migraine. Cephalalgia 29:960–968, 19298544, 10.1111/j.1468-2982.2008.01824.x, 1:STN:280:DC%2BD1Mrmt1aktA%3D%3DCrossRefPubMed
23.
go back to reference Scher AI, Terwindt GM, Picavet HS, Verschuren WM, Ferrari MD, Launer LJ (2005) Cardiovascular risk factors and migraine: the GEM population-based study. Neurology 64:614–620, 15728281, 1:STN:280:DC%2BD2M%2FpvVyjsg%3D%3DCrossRefPubMed Scher AI, Terwindt GM, Picavet HS, Verschuren WM, Ferrari MD, Launer LJ (2005) Cardiovascular risk factors and migraine: the GEM population-based study. Neurology 64:614–620, 15728281, 1:STN:280:DC%2BD2M%2FpvVyjsg%3D%3DCrossRefPubMed
24.
go back to reference Rao R, Rosati A, Liberini P, Gipponi S, Venturelli E, Sapia E, Ambrosi C, Padovani A (2008) Cerebrovascular risk factors and MRI abnormalities in migraine. Neurol Sci 29:S144–S145, 18545917, 10.1007/s10072-008-0907-4CrossRefPubMed Rao R, Rosati A, Liberini P, Gipponi S, Venturelli E, Sapia E, Ambrosi C, Padovani A (2008) Cerebrovascular risk factors and MRI abnormalities in migraine. Neurol Sci 29:S144–S145, 18545917, 10.1007/s10072-008-0907-4CrossRefPubMed
25.
go back to reference Del Sette M, Dinia L, Bonzano L, Roccatagliata L, Finocchi C, Parodi RC, Sivori G, Gandolfo C (2008) White matter lesions in migraine and right-to-left shunt: a conventional and diffusion MRI study. Cephalalgia 28:376–382, 18294247, 10.1111/j.1468-2982.2008.01544.x, 1:STN:280:DC%2BD1c7ls1Khug%3D%3DCrossRefPubMed Del Sette M, Dinia L, Bonzano L, Roccatagliata L, Finocchi C, Parodi RC, Sivori G, Gandolfo C (2008) White matter lesions in migraine and right-to-left shunt: a conventional and diffusion MRI study. Cephalalgia 28:376–382, 18294247, 10.1111/j.1468-2982.2008.01544.x, 1:STN:280:DC%2BD1c7ls1Khug%3D%3DCrossRefPubMed
26.
go back to reference Intiso D, Di Rienso F, Rinaldi G, Zarrelli MM, Giannatempo GM, Crociani P, Di Viesti P, Simone P (2006) Brain MRI white matter lesions in migraine patients: is there a relationship with antiphospholipid antibodies and coagulation parameters? Eur J Neurol 13:1364–1369, 17116221, 10.1111/j.1468-1331.2006.01519.x, 1:STN:280:DC%2BD28not1agtQ%3D%3DCrossRefPubMed Intiso D, Di Rienso F, Rinaldi G, Zarrelli MM, Giannatempo GM, Crociani P, Di Viesti P, Simone P (2006) Brain MRI white matter lesions in migraine patients: is there a relationship with antiphospholipid antibodies and coagulation parameters? Eur J Neurol 13:1364–1369, 17116221, 10.1111/j.1468-1331.2006.01519.x, 1:STN:280:DC%2BD28not1agtQ%3D%3DCrossRefPubMed
27.
go back to reference Headache Classificiation Subcommittee of the International Headache Society (2004) The international classification of headache disorders: 2nd edition. Cephalalgia 24(Suppl 1):9–160 Headache Classificiation Subcommittee of the International Headache Society (2004) The international classification of headache disorders: 2nd edition. Cephalalgia 24(Suppl 1):9–160
28.
go back to reference Vermeer SE, Hollander M, van Dijk EJ, Hofman A, Koudstaal PJ, Breteler MMB (2003) Silent brain infarcts and white matter lesions increase stroke risk in general population. Stroke 34:1126–1129, 12690219, 10.1161/01.STR.0000068408.82115.D2CrossRefPubMed Vermeer SE, Hollander M, van Dijk EJ, Hofman A, Koudstaal PJ, Breteler MMB (2003) Silent brain infarcts and white matter lesions increase stroke risk in general population. Stroke 34:1126–1129, 12690219, 10.1161/01.STR.0000068408.82115.D2CrossRefPubMed
29.
go back to reference Dalkara T, Nozari A, Moskowitz MA (2010) Migraine aura pathophysiology: the role of blood vessels and microembolisation. Lancet Neurol 9:309–317, 20170844, 10.1016/S1474-4422(09)70358-8, 1:CAS:528:DC%2BC3cXjs12lurk%3DPubMedCentralCrossRefPubMed Dalkara T, Nozari A, Moskowitz MA (2010) Migraine aura pathophysiology: the role of blood vessels and microembolisation. Lancet Neurol 9:309–317, 20170844, 10.1016/S1474-4422(09)70358-8, 1:CAS:528:DC%2BC3cXjs12lurk%3DPubMedCentralCrossRefPubMed
30.
go back to reference Rocca MA, Colombo B, Inglese M, Codella M, Comi G, Filippi M (2003) A diffusion tensor magnetic resonance imaging study of brain tissue from patients with migraine. J Neurol Neurosurg Psychiatry 74:501–503, 12640073, 10.1136/jnnp.74.4.501, 1:STN:280:DC%2BD3s7is1SjtA%3D%3DPubMedCentralCrossRefPubMed Rocca MA, Colombo B, Inglese M, Codella M, Comi G, Filippi M (2003) A diffusion tensor magnetic resonance imaging study of brain tissue from patients with migraine. J Neurol Neurosurg Psychiatry 74:501–503, 12640073, 10.1136/jnnp.74.4.501, 1:STN:280:DC%2BD3s7is1SjtA%3D%3DPubMedCentralCrossRefPubMed
31.
go back to reference Valfrè W, Rainero I, Bergui M, Pinessi L (2008) Voxel-based morphometry reveals gray matter abnormalities in migraine. Headache 48:109–117, 18184293, 10.1111/j.1526-4610.2007.00723.xCrossRefPubMed Valfrè W, Rainero I, Bergui M, Pinessi L (2008) Voxel-based morphometry reveals gray matter abnormalities in migraine. Headache 48:109–117, 18184293, 10.1111/j.1526-4610.2007.00723.xCrossRefPubMed
32.
go back to reference Aamodt AH, Stovner LJ, Hagen K, Bråthen G, Zwart J (2006) Headache prevalence related to smoking and alcohol use. The Head-HUNT Study. Eur J Neurol 13:1233–1238, 17038038, 10.1111/j.1468-1331.2006.01492.x, 1:STN:280:DC%2BD28ngs1SltA%3D%3DCrossRefPubMed Aamodt AH, Stovner LJ, Hagen K, Bråthen G, Zwart J (2006) Headache prevalence related to smoking and alcohol use. The Head-HUNT Study. Eur J Neurol 13:1233–1238, 17038038, 10.1111/j.1468-1331.2006.01492.x, 1:STN:280:DC%2BD28ngs1SltA%3D%3DCrossRefPubMed
33.
go back to reference López-Mesonero L, Márquez S, Parra P, Gámez-Leyva G, Muňoz P, Pascual J (2009) Smoking as a precipitating factor for migraine: a survey in medical students. J Headache Pain 10:101–103, 19184325, 10.1007/s10194-009-0098-2PubMedCentralCrossRefPubMed López-Mesonero L, Márquez S, Parra P, Gámez-Leyva G, Muňoz P, Pascual J (2009) Smoking as a precipitating factor for migraine: a survey in medical students. J Headache Pain 10:101–103, 19184325, 10.1007/s10194-009-0098-2PubMedCentralCrossRefPubMed
34.
go back to reference Welch GN, Loscalzo J (1998) Mechanisms of disease: homocysteine and atherothrombosis. N Engl J Med 338:1042–1050, 9535670, 10.1056/NEJM199804093381507, 1:CAS:528:DyaK1cXislaqtr4%3DCrossRefPubMed Welch GN, Loscalzo J (1998) Mechanisms of disease: homocysteine and atherothrombosis. N Engl J Med 338:1042–1050, 9535670, 10.1056/NEJM199804093381507, 1:CAS:528:DyaK1cXislaqtr4%3DCrossRefPubMed
35.
go back to reference Stuhlinger MC, Stanger O (2005) Asymmetric dimethyl-l-arginine (ADMA): a possible link between homocyst(e)ine and endothelial dysfunction. Curr Drug Metab 6:3–14, 15720202, 10.2174/1389200052997393CrossRefPubMed Stuhlinger MC, Stanger O (2005) Asymmetric dimethyl-l-arginine (ADMA): a possible link between homocyst(e)ine and endothelial dysfunction. Curr Drug Metab 6:3–14, 15720202, 10.2174/1389200052997393CrossRefPubMed
36.
go back to reference Boger RH, Sydow K, Borlak J, Thum T, Lenzen H, Schubert B, Tsikas D, Bode-Boger SM (2000) LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases. Circ Res 87:99–105, 10903992, 1:CAS:528:DC%2BD3cXlt1aitbo%3DCrossRefPubMed Boger RH, Sydow K, Borlak J, Thum T, Lenzen H, Schubert B, Tsikas D, Bode-Boger SM (2000) LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases. Circ Res 87:99–105, 10903992, 1:CAS:528:DC%2BD3cXlt1aitbo%3DCrossRefPubMed
37.
go back to reference Chrysohoou C, Pitsavos C, Skoumas J, Masoura C, Katinioti A, Panagiotakos D, Stefanadis C (2007) The emerging anti-inflammatory role of HDL-cholesterol, illustrated in cardiovascular disease free population; the ATTICA study. Int J Cardiol 122:29–33, 17188378, 10.1016/j.ijcard.2006.11.010CrossRefPubMed Chrysohoou C, Pitsavos C, Skoumas J, Masoura C, Katinioti A, Panagiotakos D, Stefanadis C (2007) The emerging anti-inflammatory role of HDL-cholesterol, illustrated in cardiovascular disease free population; the ATTICA study. Int J Cardiol 122:29–33, 17188378, 10.1016/j.ijcard.2006.11.010CrossRefPubMed
38.
go back to reference Boysen G, Brander T, Christensen H, Gideon R, Truelsen T (2003) Homocysteine and risk of recurrent stroke. Stroke 34:1258–1261, 12702838, 10.1161/01.STR.0000069017.78624.37, 1:CAS:528:DC%2BD3sXjtFGlsro%3DCrossRefPubMed Boysen G, Brander T, Christensen H, Gideon R, Truelsen T (2003) Homocysteine and risk of recurrent stroke. Stroke 34:1258–1261, 12702838, 10.1161/01.STR.0000069017.78624.37, 1:CAS:528:DC%2BD3sXjtFGlsro%3DCrossRefPubMed
39.
go back to reference Chambers JC, McGregor A, Jean-Marie J, Obeid OA, Kooner JS (1999) Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia: an effect reversible with vitamin C therapy. Circulation 99:1156–1160, 10069782, 1:CAS:528:DyaK1MXitVelsL8%3DCrossRefPubMed Chambers JC, McGregor A, Jean-Marie J, Obeid OA, Kooner JS (1999) Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia: an effect reversible with vitamin C therapy. Circulation 99:1156–1160, 10069782, 1:CAS:528:DyaK1MXitVelsL8%3DCrossRefPubMed
40.
go back to reference Hering-Hanit R, Gadoth N, Yavetz A, Gavendo S, Sela B (2001) Is blood homocysteine elevated in migraine? Headache 41:779–781, 11576202, 10.1046/j.1526-4610.2001.01143.x, 1:STN:280:DC%2BD3MngvVGhsg%3D%3DCrossRefPubMed Hering-Hanit R, Gadoth N, Yavetz A, Gavendo S, Sela B (2001) Is blood homocysteine elevated in migraine? Headache 41:779–781, 11576202, 10.1046/j.1526-4610.2001.01143.x, 1:STN:280:DC%2BD3MngvVGhsg%3D%3DCrossRefPubMed
41.
go back to reference Hagen K, Bjøro T, Zwart JA, Vatten L, Stovner LJ, Bovim G (2001) Low headache prevalence amongst women with high TSH values. Eur J Neurol 8:693–699, 11784355, 10.1046/j.1468-1331.2001.00310.x, 1:STN:280:DC%2BD38%2FmvVymug%3D%3DCrossRefPubMed Hagen K, Bjøro T, Zwart JA, Vatten L, Stovner LJ, Bovim G (2001) Low headache prevalence amongst women with high TSH values. Eur J Neurol 8:693–699, 11784355, 10.1046/j.1468-1331.2001.00310.x, 1:STN:280:DC%2BD38%2FmvVymug%3D%3DCrossRefPubMed
42.
go back to reference Rainero I, Ferrero M, Rubino E, Valfrè W, Pellegrino M, Arvat E, Giordano R, Ghigo E, Limone P, Pinessi L (2006) Endocrine function is altered in chronic migraine patients with medication-overuse. Headache 46:1309–1310, 10.1111/j.1526-4610.2006.00409.xCrossRef Rainero I, Ferrero M, Rubino E, Valfrè W, Pellegrino M, Arvat E, Giordano R, Ghigo E, Limone P, Pinessi L (2006) Endocrine function is altered in chronic migraine patients with medication-overuse. Headache 46:1309–1310, 10.1111/j.1526-4610.2006.00409.xCrossRef
43.
go back to reference Squizzato A, Gerdes VEA, Brandjes DPM, Büller HR, Stam J (2005) Thyroid diseases and cerebrovascular disease. Stroke 36:2302–2310, 16179578, 10.1161/01.STR.0000181772.78492.07, 1:STN:280:DC%2BD2MrhvFyquw%3D%3DCrossRefPubMed Squizzato A, Gerdes VEA, Brandjes DPM, Büller HR, Stam J (2005) Thyroid diseases and cerebrovascular disease. Stroke 36:2302–2310, 16179578, 10.1161/01.STR.0000181772.78492.07, 1:STN:280:DC%2BD2MrhvFyquw%3D%3DCrossRefPubMed
44.
go back to reference Stone NJ (1994) Secondary causes of hyperlipidemia. Med Clin North Am 78:117–141, 8283927, 1:STN:280:DyaK2c7htFKhsg%3D%3DPubMed Stone NJ (1994) Secondary causes of hyperlipidemia. Med Clin North Am 78:117–141, 8283927, 1:STN:280:DyaK2c7htFKhsg%3D%3DPubMed
45.
go back to reference Bic Z, Blix GG, Hopp HP, Leslie FM, Schell MJ (1999) The influence of a low fat-diet on incidence and severity of migraine headaches. J Women’s Health Gender Based Med 8:623–630, 10.1089/jwh.1.1999.8.623, 1:STN:280:DC%2BD3c3ps1Cmug%3D%3DCrossRef Bic Z, Blix GG, Hopp HP, Leslie FM, Schell MJ (1999) The influence of a low fat-diet on incidence and severity of migraine headaches. J Women’s Health Gender Based Med 8:623–630, 10.1089/jwh.1.1999.8.623, 1:STN:280:DC%2BD3c3ps1Cmug%3D%3DCrossRef
46.
go back to reference Heinecke JW, Kawamura M, Suzuki L, Chait A (1993) Oxidation of low-density lipoprotein by thiols: superoxide-dependent and independent mechanisms. J Lipid Res 34:2051–2061, 8301226, 1:CAS:528:DyaK2cXntFSlsw%3D%3DPubMed Heinecke JW, Kawamura M, Suzuki L, Chait A (1993) Oxidation of low-density lipoprotein by thiols: superoxide-dependent and independent mechanisms. J Lipid Res 34:2051–2061, 8301226, 1:CAS:528:DyaK2cXntFSlsw%3D%3DPubMed
47.
go back to reference Rapp JH, Pan XM, Neumann M, Hong M, Hollenbeck K, Liu J (2008) Microemboli composed of cholesterol crystals disrupt the blood–brain barrier and reduce cognition. Stroke 39:2354–2361, 18566307, 10.1161/STROKEAHA.107.496737, 1:CAS:528:DC%2BD1cXos12itbs%3DCrossRefPubMed Rapp JH, Pan XM, Neumann M, Hong M, Hollenbeck K, Liu J (2008) Microemboli composed of cholesterol crystals disrupt the blood–brain barrier and reduce cognition. Stroke 39:2354–2361, 18566307, 10.1161/STROKEAHA.107.496737, 1:CAS:528:DC%2BD1cXos12itbs%3DCrossRefPubMed
48.
go back to reference Weir CJ, Muir SW, Walters MR, Lees KR (2003) Serum urate as an independent predictor of poor outcome and vascular events after acute stroke. Stroke 34:1951–1957, 12843346, 10.1161/01.STR.0000081983.34771.D2CrossRefPubMed Weir CJ, Muir SW, Walters MR, Lees KR (2003) Serum urate as an independent predictor of poor outcome and vascular events after acute stroke. Stroke 34:1951–1957, 12843346, 10.1161/01.STR.0000081983.34771.D2CrossRefPubMed
49.
go back to reference Dawson J, Quinn TQ, Walter MR (2007) Xanthine oxidase inhibition—a new paradigm in management of cardiovascular risk. Curr Med Chem 14:1879–1886, 17627523, 10.2174/092986707781058797, 1:CAS:528:DC%2BD2sXnvFanu74%3DCrossRefPubMed Dawson J, Quinn TQ, Walter MR (2007) Xanthine oxidase inhibition—a new paradigm in management of cardiovascular risk. Curr Med Chem 14:1879–1886, 17627523, 10.2174/092986707781058797, 1:CAS:528:DC%2BD2sXnvFanu74%3DCrossRefPubMed
50.
go back to reference Chamorro A, Obach V, Cervera A, Revilla M, Deulofeu R, Aponte JH (2002) Prognostic significance of uric acid serum concentration in patients with acute ischemic stroke. Stroke 33:1048–1052, 11935059, 10.1161/hs0402.105927, 1:CAS:528:DC%2BD38Xjt1ynu7g%3DCrossRefPubMed Chamorro A, Obach V, Cervera A, Revilla M, Deulofeu R, Aponte JH (2002) Prognostic significance of uric acid serum concentration in patients with acute ischemic stroke. Stroke 33:1048–1052, 11935059, 10.1161/hs0402.105927, 1:CAS:528:DC%2BD38Xjt1ynu7g%3DCrossRefPubMed
Metadata
Title
Risk factors of migraine-related brain white matter hyperintensities: an investigation of 186 patients
Authors
Anita Trauninger
Eszter Leél-Őssy
David Olayinka Kamson
László Pótó
Mihály Aradi
Ferenc Kövér
Marianna Imre
Hedvig Komáromy
Szilvia Erdélyi-Botor
Ágnes Patzkó
Zoltán Pfund
Publication date
01-02-2011
Publisher
Springer Milan
Published in
The Journal of Headache and Pain / Issue 1/2011
Print ISSN: 1129-2369
Electronic ISSN: 1129-2377
DOI
https://doi.org/10.1007/s10194-011-0299-3

Other articles of this Issue 1/2011

The Journal of Headache and Pain 1/2011 Go to the issue

Acknowledgment to referees

Acknowledgment to referees